Articles
| Open Access |
DOI: Study Of The Market Of Drugs Used In Hepatosis
Urunova Iroda Isroil Qizi , Assistant Of The Department Of Pharmaceutical Organization Faculty Of Pharmacy Tashkent Pharmaceutical Institute, UzbekistanAbstract
This article reveals the need for study of the market of drugs used in hepatosis, it is rather difficult to substantiate and systematize the treatment of fatty hepatosis with such a variety of causes that cause it. therapy should be aimed at eliminating the causes, at stopping the syndromes of impaired digestion and absorption, at restoring the function of the liver and biliary system. this excludes the intake of certain drugs and alcohol abuse.
Keywords
Hepatosis, drugs, steatohepatitis, pharmaceutical market
References
Babak O. Ya. Chronic hepatitis. - K .: Blitz-Print, 1999
Golubchikov M.V. Statistical insight into the ailments of the population of Ukraine on the ailments of the liver and the youngsters // Modern gastroenterology and hepatology. - 2000.
Grigor'eva G.S., Kirichok L.M., Konakhovich N.F. ta in. //. Complex solution as a way of increasing a certain amount of microelements // Sovr. probl. toxicology. - 1998.
Vovk A.D., Tatyanka N.V., Lyashok. OV, Slobodyanik M. Ya. Therapeutic efficacy of Antral in viral hepatitis B // Prospects for the creation of synthetic gspatoprotectors in Ukraine: Abstracts. report republ. scientific. -practice. conf. - Kharkov, 1993
Krasnyuk EP, Pustylnik ED The effectiveness of the new hepatoprotector Antral in the treatment of patients with chronic toxic liver damage // Medical. a business. - 1994.
Petrunya A.M. Introduced to Antral on immune status and microcirculation in patients with chronic viral hepatitis // Infectious diseases. - Vip. IV. - Lviv: Esculap, 1996
Rachkauskas GS Clinical and immunological parameters in the treatment of patients with chronic alcoholism with liver pathology by Antral // Ecology of the industrial region of Donbas: Materials of IV sciences. -practice. conf. - Kiev; Luhansk, 1994.
Article Statistics
Copyright License
Copyright (c) 2021 The American Journal of Medical Sciences and Pharmaceutical Research
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain the copyright of their manuscripts, and all Open Access articles are disseminated under the terms of the Creative Commons Attribution License 4.0 (CC-BY), which licenses unrestricted use, distribution, and reproduction in any medium, provided that the original work is appropriately cited. The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.